Comparison
L-Theanine vs Tirzepatide
Side-by-side of L-Theanine and Tirzepatide. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
L-Theanine
L-theanine is a non-protein amino acid found in tea leaves. The most-replicated nootropic; pairs with caffeine at 1:1 (100-200 mg each) for acute focus.
Tirzepatide
Tirzepatide for weight loss: dual GIP/GLP-1 agonist sold as Mounjaro and Zepbound. SURMOUNT-1 showed 22.5% mean body-weight loss at 15 mg over 72 weeks.
Effects at a glance
L-Theanine
- •Non-protein amino acid in tea; the most-replicated nootropic in the human RCT literature
- •Caffeine + theanine at 1:1 (100-200 mg each) is the gold-standard acute focus stack
- •Solo doses of 200-400 mg reduce subjective stress and improve sleep quality
- •Increases alpha-wave EEG activity within 30-45 minutes of 200 mg oral dose
- •Crosses blood-brain barrier; bioavailability high, half-life 60-90 minutes
- •Clean safety record; minimal interactions at supplement doses
Tirzepatide
- •Dual GIP plus GLP-1 receptor agonist with a ~5-day half-life supporting once-weekly subcutaneous dosing
- •SURMOUNT-1 reported ~22.5% mean body-weight loss at 15 mg over 72 weeks versus 2.4% on placebo
- •Lowers HbA1c by ~1.9 to 2.6 percentage points in type 2 diabetes across SURPASS trials
- •Outperformed semaglutide 1.0 mg head-to-head on weight loss and HbA1c in SURPASS-2
- •GI effects (nausea, diarrhea, vomiting) drive most discontinuations and ease with slow titration
- •Lean-mass loss observed in body-composition substudies; resistance training and protein intake mitigate this
Side-by-side
| Attribute | L-Theanine | Tirzepatide |
|---|---|---|
| Category | supplement | pharmaceutical |
| Also known as | theanine, gamma-glutamylethylamide | Mounjaro, Zepbound, LY3298176 |
| Half-life (hr) ↗ | 1.5 | 120 |
| Typical dose (mg) ↗ | 200 | 10 |
| Dosing frequency | as needed (with caffeine) or daily | weekly |
| Routes | oral | subcutaneous |
| Onset (hr) | 0.5 | 24 |
| Peak (hr) | 1 | 72 |
| Molecular weight | 174.2 | 4813.45 |
| Molecular formula | C7H14N2O3 | C225H348N48O68 |
| Mechanism | Crosses BBB; modulates GABA/dopamine/serotonin (modest); increases alpha-wave EEG activity; dampens stress-induced sympathetic response without sedation. | Synthetic 39-amino-acid peptide that activates both GIP and GLP-1 receptors. Potentiates glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and acts on hypothalamic and brainstem satiety circuits. |
| Legal status | OTC dietary supplement | Prescription only; FDA-approved 2022 (T2DM, Mounjaro) and 2023 (chronic weight management, Zepbound) |
| WADA status | allowed | allowed |
| DEA / Rx | OTC supplement | Rx only (not a controlled substance) |
| Pregnancy | Insufficient supplement-dose data; tea-source intake safe | Not recommended; discontinue 2 months before planned pregnancy |
| CAS | 3081-61-6 | 2023788-19-2 |
| PubChem CID | 439378 | 156588324 |
| Wikidata | Q909931 | Q105099794 |
Safety profile
L-Theanine
Common side effects
- mild GI upset (rare)
- headache (rare)
Contraindications
- pregnancy / lactation (insufficient data at supplement doses)
- concurrent strong GABAergics without caution
Interactions
- caffeine: synergistic for acute focus; dampens jitter without blunting alertness(minor)
- benzodiazepines / alcohol: potential additive sedation(minor)
Tirzepatide
Common side effects
- nausea
- diarrhea
- vomiting
- constipation
- decreased appetite
- injection-site reactions
- fatigue
- abdominal pain
Contraindications
- personal or family history of medullary thyroid carcinoma
- multiple endocrine neoplasia type 2
- pregnancy
- history of pancreatitis (use caution)
- severe gastroparesis
Interactions
- insulin: additive hypoglycemia risk; insulin dose typically reduced(major)
- sulfonylureas (glipizide, glyburide): hypoglycemia risk, sulfonylurea dose often reduced(major)
- oral medications (general): delayed gastric emptying can alter absorption kinetics(moderate)
- oral contraceptives: reduced exposure after first dose; backup contraception recommended for 4 weeks after initiation and each dose escalation(moderate)
- warfarin: monitor INR due to altered absorption(moderate)
Which Should You Take?
L-Theanine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. Tirzepatide is the right call when one of the conditionals below applies.
- → If your priority is focus or working memory, pick L-Theanine.
- → If your priority is stress and HPA-axis regulation, pick L-Theanine.
- → If your priority is metabolic health and glucose control, pick Tirzepatide.
- → If your priority is fat loss, pick Tirzepatide.
Edge case: If you want to avoid prescription-only, L-Theanine is the more accessible choice.
Default choice: L-Theanine. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for Tirzepatide only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between L-Theanine and Tirzepatide?
L-Theanine and Tirzepatide differ in category (supplement vs pharmaceutical), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, L-Theanine or Tirzepatide?
L-Theanine half-life is 1.5 hours; Tirzepatide half-life is 120 hours.
Can you stack L-Theanine with Tirzepatide?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper